PainReform Ltd. (NASDAQ: PRFX), a clinical-stage pharmaceutical company specializing in innovative pain management solutions, experienced an extraordinary 500% surge in its stock price today. This dramatic rise has caught the attention of investors and analysts alike, raising questions about the factors fueling such rapid growth. A Breakthrough in Pain Management PainReform is focused on addressing […]